1.25
price up icon0.00%   0.00
after-market Handel nachbörslich: 1.24 -0.01 -0.80%
loading
Schlusskurs vom Vortag:
$1.25
Offen:
$1.25
24-Stunden-Volumen:
115.48K
Relative Volume:
0.61
Marktkapitalisierung:
$103.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.65M
KGV:
-3.7639
EPS:
-0.3321
Netto-Cashflow:
$-15.84M
1W Leistung:
+13.64%
1M Leistung:
+8.70%
6M Leistung:
-22.84%
1J Leistung:
-51.36%
1-Tages-Spanne:
Value
$1.19
$1.28
1-Wochen-Bereich:
Value
$1.07
$1.31
52-Wochen-Spanne:
Value
$0.7709
$3.12

Cardiol Therapeutics Inc Stock (CRDL) Company Profile

Name
Firmenname
Cardiol Therapeutics Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
18
Name
Twitter
Name
Nächster Verdiensttermin
2025-05-20
Name
Neueste SEC-Einreichungen
Name
CRDL's Discussions on Twitter

Vergleichen Sie CRDL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
CRDL
Cardiol Therapeutics Inc
1.25 90.91M 0 -21.65M -15.84M -0.3321
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.35 50.14B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
168.63 72.38B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.79 4.22M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 45.51B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.78 19.45B 16.54B -1.64B 749.00M -1.45

Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-28 Eingeleitet Rodman & Renshaw Buy
2024-06-26 Eingeleitet ROTH MKM Buy
2024-04-22 Eingeleitet H.C. Wainwright Buy

Cardiol Therapeutics Inc Aktie (CRDL) Neueste Nachrichten

pulisher
May 30, 2025

(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - news.stocktradersdaily.com

May 30, 2025
pulisher
May 29, 2025

Cardiol Therapeutics Announces AGM Results and New Board Member - TipRanks

May 29, 2025
pulisher
May 29, 2025

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders | CRDL Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders - Newsfile

May 29, 2025
pulisher
May 29, 2025

Ex-Eli Lilly Chief Medical Officer Strengthens Cardiol Board as Critical Phase III Trial Nears Completion - Stock Titan

May 29, 2025
pulisher
May 28, 2025

Cardiol Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 28, 2025
pulisher
May 27, 2025

Cardiol Therapeutics to Webcast Virtual Annual General Meeting o - GuruFocus

May 27, 2025
pulisher
May 27, 2025

(CRDL) Market Insights and Trading Signals (CRDL:CA) - news.stocktradersdaily.com

May 27, 2025
pulisher
May 27, 2025

Cardiol Therapeutics Inc. - Baystreet.ca

May 27, 2025
pulisher
May 27, 2025

Stocks In Play: Cardiol Therapeutics Inc. - Barchart.com

May 27, 2025
pulisher
May 27, 2025

Cardiol Therapeutics to Webcast AGM Amidst Ongoing Clinical Trials - TipRanks

May 27, 2025
pulisher
May 27, 2025

Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT - Newsfile

May 27, 2025
pulisher
May 27, 2025

Cardiol Therapeutics Announces Virtual AGM: How Shareholders Can Participate Online May 28 - Stock Titan

May 27, 2025
pulisher
May 27, 2025

Cardiol Therapeutics (OTCMKTS:CRTPF) Stock Price Up 2.8% – Here’s Why - Defense World

May 27, 2025
pulisher
May 24, 2025

(CRDL) Investment Performance Report (CRDL:CA) - news.stocktradersdaily.com

May 24, 2025
pulisher
May 22, 2025

AMD Will Be as ‘Aggressive as Possible’ to Challenge Nvidia - The Globe and Mail

May 22, 2025
pulisher
May 22, 2025

(CRDL) Stock Market Analysis (CRDL:CA) - news.stocktradersdaily.com

May 22, 2025
pulisher
May 22, 2025

Cardiol Therapeutics (TSE:CRDL) Stock Price Down 5.2% – Time to Sell? - Defense World

May 22, 2025
pulisher
May 14, 2025

(CRDL) Market Performance Analysis (CRDL:CA) - news.stocktradersdaily.com

May 14, 2025
pulisher
May 11, 2025

(CRDL) Strategic Equity Report (CRDL:CA) - news.stocktradersdaily.com

May 11, 2025
pulisher
May 08, 2025

(CRDL) Advanced Trading Insights (CRDL:CA) - news.stocktradersdaily.com

May 08, 2025
pulisher
May 08, 2025

Cardiol Therapeutics Inc. (NASDAQ:CRDL) Given Consensus Rating of “Buy” by Analysts - Defense World

May 08, 2025
pulisher
May 06, 2025

Envestnet Asset Management Inc. Makes New Investment in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World

May 06, 2025
pulisher
May 05, 2025

Lodgement of CONNEQT Pulse Device with the TGA - Investing News Network

May 05, 2025
pulisher
May 03, 2025

(CRDL) Trading Performance and Risk Management (CRDL:CA) - news.stocktradersdaily.com

May 03, 2025
pulisher
Apr 30, 2025

(CRDL) Daily Stock Insights (CRDL:CA) - news.stocktradersdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

March Quarterly Activities Report - Investing News Network

Apr 30, 2025
pulisher
Apr 30, 2025

March Quarterly Appendix 4C - Investing News Network

Apr 30, 2025
pulisher
Apr 30, 2025

Cardiol Therapeutics (TSE:CRDL) Trading Up 6.7% – What’s Next? - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Profound Medical Corp. - Baystreet.ca

Apr 29, 2025
pulisher
Apr 29, 2025

Stocks in play: Cardiol Therapeutics Inc. - The Globe and Mail

Apr 29, 2025
pulisher
Apr 29, 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors | CRDL Stock News - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Board Amid Phase III Trial Progress - TipRanks

Apr 29, 2025
pulisher
Apr 29, 2025

The S&P 500 Is Doing Something That Hasn't Been Seen in Nearly 100 Years. Here Are the 10 Most Important Stocks to Keep an Eye On. - The Globe and Mail

Apr 29, 2025
pulisher
Apr 29, 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors - Newsfile

Apr 29, 2025
pulisher
Apr 29, 2025

Cardiol Therapeutics nominates ex-Eli Lilly CMO to board - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

Cardiol Therapeutics announces annual shareholder meeting By Investing.com - Investing.com India

Apr 29, 2025
pulisher
Apr 28, 2025

Cardiol Therapeutics announces annual shareholder meeting - Investing.com

Apr 28, 2025
pulisher
Apr 28, 2025

Cardiol Therapeutics Schedules Virtual Annual General Meeting for May 2025 - TipRanks

Apr 28, 2025
pulisher
Apr 27, 2025

First patient dosed in Phase IIb imaging for Brain Mets - Investing News Network

Apr 27, 2025
pulisher
Apr 27, 2025

(CRDL) Strategic Market Analysis (CRDL:CA) - news.stocktradersdaily.com

Apr 27, 2025
pulisher
Apr 26, 2025

A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David ElsleyCardiol Therapeutics - thedeepdive.ca

Apr 26, 2025
pulisher
Apr 25, 2025

Long Term Trading Analysis for (CRDL) (CRDL:CA) - news.stocktradersdaily.com

Apr 25, 2025
pulisher
Apr 22, 2025

(CRDL) Risk-Controlled Trading Report (CRDL:CA) - news.stocktradersdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Cardiol Therapeutics Stock: Is Cannabis Potential Priced In? - Nasdaq

Apr 22, 2025
pulisher
Apr 21, 2025

Genocea Biosciences (NASDAQ:GNCA) versus Cardiol Therapeutics (NASDAQ:CRDL) Head-To-Head Review - Defense World

Apr 21, 2025
pulisher
Apr 19, 2025

(CRDL) Investment Analysis and Advice (CRDL:CA) - news.stocktradersdaily.com

Apr 19, 2025
pulisher
Apr 19, 2025

Roth Capital Has Bearish Forecast for CRDL Q1 Earnings - Defense World

Apr 19, 2025
pulisher
Apr 19, 2025

Cardiol Therapeutics (CRDL) Projected to Post Quarterly Earnings on Monday - Defense World

Apr 19, 2025
pulisher
Apr 18, 2025

Cardiol Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

Apr 18, 2025
pulisher
Apr 18, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Earns “Buy” Rating from HC Wainwright - Defense World

Apr 18, 2025

Finanzdaten der Cardiol Therapeutics Inc-Aktie (CRDL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_specialty_generic RGC
$877.00
price up icon 18.36%
drug_manufacturers_specialty_generic HCM
$13.89
price up icon 0.22%
$123.02
price down icon 0.52%
drug_manufacturers_specialty_generic RDY
$14.72
price down icon 0.20%
$318.85
price down icon 0.47%
$16.78
price down icon 4.28%
Kapitalisierung:     |  Volumen (24h):